Here’s what you need to know.
1. The device is designed to improve adenoma detection rates during a colonoscopy over standard colonoscopy.
2. Peer-reviewed studies are still required for the Endocuff Vision, a device Olympus recently launched.
3. The material, hinge design and moment of force are similar among the two devices.
4. An FDA analysis determined that Endocuff results in a “statistically and clinically relevant improvement in adenoma detection rate, as compared to unassisted colonoscopy.” The analysis was based on several multi-center studies.
More articles on gastroenterology/endoscopy:
Olympus, Boston Scientific & more — 3 GI company key notes
GI leader to know: Dr. Eric Osgard of Gastroenterology Consultants
ACG creates new clinical guideline for abnormal liver chemistries: 5 things to know
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.